By downregulating adhesion molecule expression via the LPS/IKK/NF-κB pathway, MβCD may be able to inhibit monocyte endothelial adhesion, which indicates MβCD may have anti-atherosclerosis effects [51]. The gene discussed is NFKB1; the disease is atherosclerosis.